Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SPNE | Common Stock | Disposed to Issuer | -21K | -100% | 0 | Jan 5, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SPNE | Restricted Stock Units | Disposed to Issuer | -1.19K | -100% | 0 | Jan 5, 2023 | Common Stock | 1.19K | $0.00 | Direct | F2, F3, F4 | ||
transaction | SPNE | Restricted Stock Units | Disposed to Issuer | -2.76K | -100% | 0 | Jan 5, 2023 | Common Stock | 2.76K | $0.00 | Direct | F5, F6 | ||
transaction | SPNE | Employee Stock Option (Right to Buy) | Disposed to Issuer | -10K | -100% | 0 | Jan 5, 2023 | Common Stock | 10K | $15.68 | Direct | F7, F8 | ||
transaction | SPNE | Employee Stock Option (Right to Buy) | Disposed to Issuer | -8.8K | -100% | 0 | Jan 5, 2023 | Common Stock | 8.8K | $14.19 | Direct | F9, F10 | ||
transaction | SPNE | Employee Stock Option (Right to Buy) | Disposed to Issuer | -3.42K | -100% | 0 | Jan 5, 2023 | Common Stock | 3.42K | $18.24 | Direct | F11, F12 | ||
transaction | SPNE | Employee Stock Option (Right to Buy) | Disposed to Issuer | -10.4K | -100% | 0 | Jan 5, 2023 | Common Stock | 10.4K | $12.01 | Direct | F13, F14 | ||
transaction | SPNE | Employee Stock Option (Right to Buy) | Disposed to Issuer | -2.72K | -100% | 0 | Jan 5, 2023 | Common Stock | 2.72K | $9.93 | Direct | F15, F16 | ||
transaction | SPNE | Employee Stock Option (Right to Buy) | Disposed to Issuer | -5.93K | -100% | 0 | Jan 5, 2023 | Common Stock | 5.93K | $16.86 | Direct | F17, F18 | ||
transaction | SPNE | Employee Stock Option (Right to Buy) | Disposed to Issuer | -6.91K | -100% | 0 | Jan 5, 2023 | Common Stock | 6.91K | $12.67 | Direct | F19, F20 |
Paul Benny is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 8,721 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger. |
F2 | Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. |
F3 | The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024. |
F4 | These restricted stock units were assumed by Orthofix in the merger and replaced by 493 Orthofix restricted stock units. |
F5 | The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025. |
F6 | These restricted stock units were assumed by Orthofix in the merger and replaced by 1,149 Orthofix restricted stock units. |
F7 | The option vests as to 25% of the underlying shares on May 1, 2016 and the remaining 75% vests in twelve substantially equal quarterly installments thereafter. |
F8 | This option was assumed by Orthofix in the merger and replaced with an option to purchase 4,163 shares of Orthofix at a price of $37.67 per share. |
F9 | The option vests as to 25% of the underlying shares on January 27, 2017 and the remaining 75% vests in twelve substantially equal quarterly installments thereafter. |
F10 | This option was assumed by Orthofix in the merger and replaced with an option to purchase 3,663 shares of Orthofix at a price of $34.09 per share. |
F11 | The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% vests in twelve substantially equal quarterly installments thereafter. |
F12 | This option was assumed by Orthofix in the merger and replaced with an option to purchase 1,424 shares of Orthofix at a price of $43.82 per share. |
F13 | The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% vests in twelve substantially equal quarterly installments thereafter. |
F14 | This option was assumed by Orthofix in the merger and replaced with an option to purchase 4,328 shares of Orthofix at a price of $28.85 per share. |
F15 | The option vested in full on June 21, 2020. |
F16 | This option was assumed by Orthofix in the merger and replaced with an option to purchase 1,130 shares of Orthofix at a price of $23.86 per share. |
F17 | The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% vests in twelve substantially equal quarterly installments thereafter. |
F18 | This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,466 shares of Orthofix at a price of $40.50 per share. |
F19 | The option will vest as to 25% of the underlying shares on February 28, 2023 and the remaining 75% will vest in twelve substantially equal quarterly installments thereafter. |
F20 | This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,874 shares of Orthofix at a price of $30.44 per share. |